(Q39736137)

14 September 2017

title

Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model (English)

1 reference

14 September 2017

0 references

1 reference

lymphoblastic leukemia

1 reference

S Canale

1

1 reference

14 September 2017

C Cocco

2

1 reference

14 September 2017

C Frasson

3

1 reference

14 September 2017

E Seganfreddo

4

1 reference

14 September 2017

E Di Carlo

5

1 reference

14 September 2017

E Ognio

6

1 reference

14 September 2017

C Sorrentino

7

1 reference

14 September 2017

D Ribatti

8

1 reference

14 September 2017

A Zorzoli

9

1 reference

14 September 2017

G Basso

10

1 reference

14 September 2017

C Dufour

11

1 reference

14 September 2017

I Airoldi

12

1 reference

14 September 2017

publication date

24 June 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

25

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

1815-1824

1 reference

The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Positive and negative regulation of the IL-27 receptor during lymphoid cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Potent antitumor activity of interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Differential effects of IL-27 on human B cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Antiangiogenic and antitumor activities of IL-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Antiproliferative activity of IL-27 on melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Cancer stem cells: mirage or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Reprogramming of miRNA networks in cancer and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Histopathology of diabetic retinopathy in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Treatment of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Acute myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

miR-155: on the crosstalk between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Interleukin-27 directly induces differentiation in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of CD133 on leukemia-initiating cells in childhood ALL

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of acute lymphoblastic leukemia progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.158

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2011.158

1 reference

14 September 2017

1 reference